Astrana Health, Inc. (ASTH)
$
29.71
-0.23 (-0.77%)
Key metrics
Financial statements
Free cash flow per share
2.4025
Market cap
1.5 Billion
Price to sales ratio
0.6132
Debt to equity
0.0453
Current ratio
0.0830
Income quality
4.0342
Average inventory
0
ROE
0.0359
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
Astrana Health, Inc., a physician-centric technology-driven healthcare management company, recorded an operating income of $89,350,000.00 reflecting its earnings from core operations. The gross profit ratio stands at 0.13 indicating the efficiency of the company's production and sales operations. Additionally, the company incurred an interest expense of $33,097,000.00 which denotes its obligations related to debt servicing. The diluted EPS is $0.90 accounting for potential share dilution, and the net income ratio is 0.02 illustrating the company's profitability margin. Operating through its Care Partners, Care Delivery, and Care Enablement segments, Astrana Health utilizes its proprietary population health management and healthcare delivery platform to facilitate an integrated, value-based healthcare model, empowering the diverse providers within its network. The firm extends care coordination services to patients, families, and various health entities including primary care physicians, specialists, and health plans, ensuring a cohesive approach to patient care. Primarily serving patients with private or public insurance such as Medicare, Medicaid, health maintenance organization plans, as well as non-insured individuals, Astrana Health plays a vital role in the healthcare landscape. Formerly known as Apollo Medical Holdings, Inc., the company adopted its current name in February 2024 and has been incorporated since 1985, with its headquarters located in Alhambra, California. The stock is affordable at $25.12 making it suitable for budget-conscious investors. Moreover, it exhibits a low average trading volume of 344,522.00 indicating lower market activity which may appeal to certain investment strategies. With a market capitalization of $1,483,346,025.00 the company is classified as a small-cap player, situating it in a unique position within its industry. It is regarded as a key player in the Medical - Care Facilities industry, contributing significantly to the overall market landscape. Furthermore, the company belongs to the Healthcare sector, driving innovation and growth, thus attracting attention from investors who are looking for opportunities in emerging and stable markets alike.
Is Astrana Health, Inc. (ASTH) a good investment?
Investing in Astrana Health, Inc. (ASTH) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as B+, with a Bullish outlook. Always conduct your own research before investing.
What is Astrana Health, Inc. (ASTH)'s stock forecast?
Analysts predict Astrana Health, Inc. stock to fluctuate between $21.20 (low) and $63.20 (high) in the next 365 days, reflecting market expectations and potential volatility.
What is Astrana Health, Inc.'s market capitalization?
As of 2025-08-20, Astrana Health, Inc.'s market cap is $1,483,346,025, based on 49,927,500 outstanding shares.
How does Astrana Health, Inc. compare to competitors like Meta Platforms, Inc. Class A Common Stock?
Compared to Meta Platforms, Inc. Class A Common Stock, Astrana Health, Inc. has a Lower Market-Cap, indicating a difference in performance.
How can I buy Astrana Health, Inc. (ASTH) stock?
To buy Astrana Health, Inc. (ASTH) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for ASTH. Place an order (Market, Limit, etc.).
What is the best time to invest in Astrana Health, Inc.?
The best time to invest depends on market trends and technical indicators, which show a Bullish trend based on economic conditions and company performance.
Has Astrana Health, Inc. stock ever split?
Astrana Health, Inc.'s last stock split was 1:10 on 2015-04-27.
How did Astrana Health, Inc. perform in the last earnings report?
Revenue: $2,034,540,000 | EPS: $0.91 | Growth: -30%.
Where can I find Astrana Health, Inc.'s investor relations reports?
Visit https://www.astranahealth.com/investor-relations for detailed financial reports.
Where can I find historical stock prices for Astrana Health, Inc.?
You can explore historical data from here
What is the all-time high and low for Astrana Health, Inc. stock?
All-time high: $63.20 (2024-10-16) | All-time low: $21.20 (2025-08-07).
What are the key trends affecting Astrana Health, Inc. stock?
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News
zacks.com
Investors interested in stocks from the Medical - Outpatient and Home Healthcare sector have probably already heard of Astrana Health, Inc. (ASTH) and U.S. Physical Therapy (USPH). But which of these two stocks offers value investors a better bang for their buck right now?
seekingalpha.com
Astrana Health, Inc. (ASHT) Q2 2025 Earnings Conference Call August 7, 2025 5:30 PM ET Company Participants Brandon K. Sim - President & CEO Chandan Basho - CFO, COO & Corporate Secretary Conference Call Participants Andrew Mok - Barclays Bank PLC, Research Division Craig Jones - BofA Securities, Research Division David Michael Larsen - BTIG, LLC, Research Division Hua Ha - Robert W.
zacks.com
Astrana Health, Inc. (ASTH) came out with quarterly earnings of $0.19 per share, missing the Zacks Consensus Estimate of $0.36 per share. This compares to earnings of $0.4 per share a year ago.
zacks.com
Value investors can consider buying high earnings yield stocks like B, ASTH, STNE, PHIN and PAGP for handsome returns.
zacks.com
Investors interested in Medical - Outpatient and Home Healthcare stocks are likely familiar with Astrana Health, Inc. (ASTH) and Chemed (CHE). But which of these two stocks offers value investors a better bang for their buck right now?
zacks.com
Astrana Health, Inc. (ASTH) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
zacks.com
Investors looking for stocks in the Medical - Outpatient and Home Healthcare sector might want to consider either Astrana Health, Inc. (ASTH) or Chemed (CHE). But which of these two stocks offers value investors a better bang for their buck right now?
zacks.com
ASTH, LGCY, STM, BAYRY and KD have been added to the Zacks Rank #1 (Strong Buy) List on July 10, 2025.
prnewswire.com
ALHAMBRA, Calif. , July 2, 2025 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a physician-centric, technology-enabled healthcare company empowering providers to deliver accessible, high-quality, and high-value care to all, today announced it closed the acquisition of Prospect Health on July 1st, 2025.
prnewswire.com
ALHAMBRA, Calif. , June 2, 2025 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced that Brandon Sim, President and CEO is participating in the William Blair 2025 Growth Stock Conference, being held in Chicago, from Tuesday, June 3, 2025 to Thursday June 5, 2025 including a presentation at 10:40 am CT on Wednesday, June 4.
See all news
